Could GLP-1 drugs be anti-aging medications?
CNN, via Yahoo Health, reports early research on whether GLP-1 drugs affect biological aging. A small Eli Lilly analysis of 71 overweight tirzepatide users over the age of 50 found epigenetic clocks advanced more slowly, with no placebo group. A Novo Nordisk preprint reported similar semaglutide findings, and a Berkeley study in mice found treated mice lived longer. Experts caution the aging metrics are still in development.
Why it matters: Relevant to Maryland adults with overweight or diabetes who are weighing GLP-1 medication, and to clinicians fielding patient questions about these drugs and aging.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to health.yahoo.com. October 13, 2026.
